Antibody production
-
Antibody production
The role of point-of-care tests in tracking and curbing the COVID-19 pandemic
Coordinated strategies, efficient tracking, and vaccination are key to ensure a safe return to normal during the COVID-19 pandemic. But as regulators and policymakers work at record speed to implement…
-
Reinventing IgY biotherapeutics
An unorthodox project idea led Dr. Mara Freire, a researcher at CICECO – Aveiro Institute of Materials, from the Chemistry… Read More
-
How the environment shapes immune system development during pregnancy
Dr. Melanie Conrad, head of the Reproductive Immunology Lab at the Charité Medical University in Berlin, Germany, has dedicated her… Read More
-
How the phage display technology is boosting the production of valuable bispecific antibodies
Bispecific antibodies are valuable therapeutics due to their unique ability to engage different epitopes or antigens and thus modulate the… Read More
-
Is genetic immunization a one-size-fits-all solution to accelerate polyclonal antibody generation?
Polyclonal antibodies are valuable tools for research as secondary reagents or therapy as antivenom drugs. However, their production has largely… Read More
-
Can antibody therapeutics serve as effective tools to treat and alleviate aggressive rare diseases?
Although rare diseases are characterized by a generalized low incidence in the global population, collectively, over 7,000 different conditions affect… Read More
-
What makes antibody therapeutics uniquely fitted to fight autoimmune disorders?
Autoimmune disorders afflict almost 10% of the global population, with a particular incidence in young and middle-aged women. Despite the… Read More
-
How advanced monoclonal antibody generation methods are improving conventional envenoming treatments
Snakebite envenoming has been on WHO’s priority list of neglected tropical diseases since 2017. Due to the complexity and variability… Read More
-
What are the leading monoclonal antibody treatments for cancer?
Arresting cancer progression has evolved from the use of unspecific chemotherapies with serious adverse effects to the adoption of antibody-based… Read More
-
“Cell-based phage display is helping us isolate more biologically relevant antibodies”
Dr. Mohamed Alfaleh is an assistant professor at King Abdulaziz University (Faculty of Pharmacy, Jeddah, Saudi Arabia). Pharmacist by training,… Read More